Mylan N.V.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
535.5 M
Public Float
-
Mylan N.V.
Stock Exchange NASDAQ Stock Market
EPS
$0.46
Market Cap
$10.05 B
Shares Outstanding
515.47 M
Public Float
513 M

Profile

Address
Building 4
Hatfield Hertfordshire AL10 9UL
United Kingdom
Employees -
Website http://mylan.co.uk
Updated 07/08/2019
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe, Rest of World, and Corporate or Other.

Financials

View All
Created with Highcharts 5.0.14Mylan N.V.Net Income. Fiscal year is January-December. All values USD Millions.62462492992984884848048069669635335320132014201520162017201802505007501000
Created with Highcharts 5.0.14Mylan N.V.Sales/Revenue. Fiscal year is January-December. All values USD Millions.6 9706 9707 7687 7689 4709 47011 12111 12111 90711 90711 42811 42820132014201520162017201802.5k5k7.5k10k12.5k15k

Robert J. Coury
Executive Chairman
Rajiv Malik
President & Executive Director